Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases

Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases

Eosinophil-related diseases represent a group of pathologic conditions with highly heterogeneous clinical presentation and symptoms ranging from mild to critical. Both systemic and localized forms of disease are typically treated with glucocorticoids. The approval of novel biologic therapies targeti...

Full description

Bibliographic Details
Main Authors: Victoria del Pozo, Irina Bobolea, Manuel J. Rial, Georgina Espigol-Frigolé, Roser Solans Laqué, Jesús María Hernández-Rivas, Elvira Mora, Astrid Crespo-Lessmann, José Luis Izquierdo Alonso, María Sandra Domínguez Sosa, Juan Maza-Solano, Belén Atienza-Mateo, David Bañas-Conejero, Abraham L. Moure, Íñigo Rúa-Figueroa
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
adverse events
eosinophilic diseases
systemic glucocorticoids
biologics
tapering
treatment optimisation
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1310211/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1310211/full

Similar Items